Navigation Links
Breaks In The HIV Treatment Resulted In Devastating Results.

An International study conducted by the University of New South Wales scientists resulted in proving that breaks taken in-between the HIV treatment can be life threatening and resulted in early deaths. This study was discontinued halfway through because //they identified that the patients who took a break faced increased risk of death or suffer a progression of the disease, compared with those who took the drugs consistently.

This study had more than 5000 people participating from different countries. About 200 patients from Australia and New Zealand participated in the study.

It is widely accepted that patients stop their treatment for HIV when there is a slight improvement in their health. This is mainly done to reduce the drug’s harmful side effects such as damage to the heart, kidney and liver. They need not go in for the next degree treatment and reduce the exposure of their body to toxic chemicals, once when their body has acquired resistance with initial therapy.

But the study has shown that this is not the case and the researcher of the Australian side of the study, Associate Professor Sean Emery, said that once the treament is commenced, patients should not think of stopping it as it might prove fatal.He also mentioned that people need to think extensively before starting the treatment.

Statistic show that about 16,000 Australians suffer from HIV, and 50% of them are already going in for the antiretroviral therapies. The symptoms which probe the doctors to request their patients to commence the therapy are very lear in some cases but are ambiguous in others.

Many australians are in the practice of discontinuing the antiretroviral therapy once they have regained their immunity but this practice should be avoided now. The study was led by the US National Institute of Allergy and Infectious Diseases. It did a comparative study between two sets of patients one who were on the antiretroviral therapy, with th ose who were asked to discontinue after they regained the standard white blood cell count and told them to resume the therapy once the count declined to a lower threshold.

As such the study was to continue for a period of five years but it was discontinued when it showed devasting results. Now the study patients were being informed by their doctors to resume their medication and continue with it.


'"/>




Related medicine news :

1. Measles Breaks Out In Kashmir
2. Task Learning Made Simple By Taking Short Breaks
3. HIV Patients May Benefit From Treatment Breaks
4. Winter Warmth Breaks All Records
5. Advances in Treatment of Cataracts
6. Recommendations for Treatment of Blood Pressue
7. Treatment for Menieres disease
8. Treatment for pre-menstrual syndrome is ineffective
9. Better Treatment for obesity
10. Gene Treatment for Heart Disease
11. More People Seeking Treatment for Depression
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... ... February 17, 2017 , ... For the first time, International ... the exhibit floor for the 2017 HIMSS Conference & Exhibition at ... 2017, more than 40,000 healthcare industry professionals are expected at the conference, where ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's ... goals for each and every seminar, session and class she offers. At ... brainwave tools which help energize creativity, focus mental functions, enhance athletic focus and ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... named a finalist in the 8th Annual DecisionHealth Platinum Awards in recognition of ... Qualis Health’s work is recognized across multiple award categories, highlighting four of the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will ... Trinity Health and the U.S. Soccer Foundation announced today that they have awarded ... Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals of ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting ... on all facets of clinical trial planning and management. Pharmica discussed the importance ... more. In addition, attendees stopping by Pharmica’s booth were able to demo its ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
(Date:2/16/2017)... REDWOOD CITY, Calif. , Feb. 16, 2017 ... ), a specialty pharmaceutical company focused on the ... treatment of moderate-to-severe acute pain, announced that ... executive officer and a member of the company,s ... Mr. Angotti brings over two decades of experience ...
(Date:2/16/2017)... 16, 2017 Research and Markets has announced ... Analysis & Trends - Function, Application, Cancer Type, Technology - Forecast ... ... Market is poised to grow at a CAGR of around 28.6% ... Some of the prominent trends that the ...
Breaking Medicine Technology: